Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06672952
NA

Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Other Perceptual Indicators

Sponsor: Lindenwood University

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the dose-dependent effects of glucosyl-hesperidin (CITRAPEAK) supplementation on exercise performance, recovery indicators, blood flow, cognitive function, mood, sleep, and fuel utilization in recreationally active adults.

Key Details

Gender

All

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-04-15

Completion Date

2026-01-01

Last Updated

2025-12-12

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

400 mg CITRAPEAK® (glucosyl-hesperidin) supplementation

The active intervention consists of 400 mg of glucosyl-hesperidin (CITRAPEAK®) in capsule form.

DIETARY_SUPPLEMENT

Placebo

The placebo intervention consists of 400 mg/day of cellulose in capsule form, matching the appearance and dosage of active interventions.

DIETARY_SUPPLEMENT

200 mg CITRAPEAK® (glucosyl-hesperidin) supplementation

The active intervention includes 200 mg of glucosyl-hesperidin (CITRAPEAK®) and an additional 200 mg of cellulose in capsule form.

Locations (1)

Lindenwood University

Saint Charles, Missouri, United States